The best care for every brain™

Uncategorized

CMS Innovation

CMS Launches New Dementia Care Management Program

The Centers for Medicare & Medicaid Services (CMS) has just launched a new dementia care management program called GUIDE (Geographic Variation for Individuals with Dementia and their Caregivers). This program is designed to improve the quality of care and support for people living with dementia and their caregivers. GUIDE is a pay-for-performance program that will …

CMS Launches New Dementia Care Management Program Read More »

New Drug Donanemab Shows Promise: Advancements in Early Alzheimer’s Treatment

On July 17th, researchers from the TRAILBLAZER-ALZ2 randomized control trial of Donanemab shared the results of their study in parallel to the full publication of their findings. These results represent another remarkable development in Alzheimer’s research. This potential new treatment is showing significant capability in slowing the progression of Alzheimer’s disease, particularly in its early …

New Drug Donanemab Shows Promise: Advancements in Early Alzheimer’s Treatment Read More »

Utilization management

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management

Introduction: The recent full approval of Lecanemab (Leqembi) by the FDA has ushered in a new era in the treatment of Alzheimer’s disease. As the first disease-modifying treatment to receive such approval, Leqembi offers hope to patients with early-stage Alzheimer’s. However, its adoption poses cost implications for payers and risk-bearing health systems. In a newly …

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management Read More »

Introducing Leqembi: What You Need to Know About This Breakthrough in the Fight Against Alzheimer’s Disease

July 6th, 2023, marks a significant milestone in the battle against early Alzheimer’s disease dementia as a groundbreaking new drug, Lecanemab (Leqembi), received full FDA approval. This medication brings hope to individuals grappling with the symptoms and progression of this devastating condition. Isaac Health, at the forefront of innovative healthcare solutions, proudly positions itself as …

Introducing Leqembi: What You Need to Know About This Breakthrough in the Fight Against Alzheimer’s Disease Read More »

What You Need to Know About Concussion

In recent news, Senate Minority Leader Mitch McConnell suffered a concussion after a fall. While his condition has not been fully disclosed, the incident highlights the seriousness of concussions, particularly mild traumatic brain injury (TBI). As he recovers from the concussion, many people are curious about this common but often misunderstood injury. As a behavioral …

What You Need to Know About Concussion Read More »

Join our community

* indicates required

Request patient flyers